Who has invested in Kanaph Therapeutics?

Lotte Biologics, GC Pharma, InterVest, Premier Partners, Solidus Investment, Daily Partners are named among the investors backing Kanaph Therapeutics.

Kanaph Therapeutics Funding: $73M Raised, Series C (2024)

Kanaph Therapeutics funding overview

Kanaph Therapeutics is based in Seoul, South Korea. Kanaph Therapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Kanaph Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Lotte Biologics, GC Pharma, InterVest, Premier Partners, Solidus Investment, Daily Partners and 3 others. 9 distinct backers are named across the disclosed rounds.

Kanaph Therapeutics at a glance

Total raised: $73M
Latest round: Series C
Latest round date: January 2024
Headquarters: Seoul, South Korea
Notable investors: Lotte Biologics, GC Pharma, InterVest, Premier Partners, Solidus Investment, Daily Partners, NH Venture Investment, Aju IB Investment

Frequently asked about Kanaph Therapeutics funding

How much has Kanaph Therapeutics raised?: Kanaph Therapeutics has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Kanaph Therapeutics?: Lotte Biologics, GC Pharma, InterVest, Premier Partners, Solidus Investment, Daily Partners are named among the investors backing Kanaph Therapeutics.
What was the latest Kanaph Therapeutics funding round?: The most recent disclosed round is a Series C, announced in January 2024.
Where is Kanaph Therapeutics based?: Kanaph Therapeutics is based in Seoul, South Korea.
When did Kanaph Therapeutics last raise?: The last disclosed Kanaph Therapeutics round closed in January 2024 at Series C.

Round data for Kanaph Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seoul and backer lists below.

Kanaph Therapeutics Funding: $73M Raised, Series C (2024)

Kanaph Therapeutics funding overview

Kanaph Therapeutics at a glance

Frequently asked about Kanaph Therapeutics funding

Companies related to Kanaph Therapeutics (18)

Browse related funding lists (6)